Id |
Subject |
Object |
Predicate |
Lexical cue |
T47 |
1-2 |
PDT |
denotes |
• |
T48 |
4-6 |
DT |
denotes |
No |
T49 |
7-17 |
VBN |
denotes |
controlled |
T50 |
18-26 |
JJ |
denotes |
clinical |
T51 |
27-33 |
NNS |
denotes |
trials |
T52 |
34-39 |
VBP |
denotes |
exist |
T53 |
40-42 |
IN |
denotes |
on |
T54 |
43-46 |
DT |
denotes |
the |
T55 |
47-50 |
NN |
denotes |
use |
T56 |
51-53 |
IN |
denotes |
of |
T57 |
54-69 |
NNS |
denotes |
corticosteroids |
T58 |
70-73 |
IN |
denotes |
for |
T59 |
74-82 |
NN |
denotes |
COVID-19 |
T60 |
84-85 |
LS |
denotes |
• |
T61 |
87-90 |
NN |
denotes |
IL6 |
T62 |
91-101 |
VBZ |
denotes |
correlates |
T63 |
102-106 |
IN |
denotes |
with |
T64 |
107-115 |
NN |
denotes |
severity |
T65 |
115-116 |
-COMMA- |
denotes |
, |
T66 |
117-128 |
NN |
denotes |
criticality |
T67 |
128-129 |
-COMMA- |
denotes |
, |
T68 |
130-135 |
JJ |
denotes |
viral |
T69 |
136-140 |
NN |
denotes |
load |
T70 |
140-141 |
-COMMA- |
denotes |
, |
T71 |
142-145 |
CC |
denotes |
and |
T72 |
146-155 |
NN |
denotes |
prognosis |
T73 |
156-158 |
IN |
denotes |
of |
T74 |
159-167 |
NN |
denotes |
COVID-19 |
T75 |
169-170 |
IN |
denotes |
• |
T76 |
172-183 |
NNP |
denotes |
Tocilizumab |
T77 |
183-184 |
-COMMA- |
denotes |
, |
T78 |
185-187 |
DT |
denotes |
an |
T79 |
188-196 |
NN |
denotes |
anti-IL6 |
T80 |
196-197 |
-COMMA- |
denotes |
, |
T81 |
198-201 |
MD |
denotes |
can |
T82 |
202-208 |
VB |
denotes |
confer |
T83 |
209-216 |
NN |
denotes |
benefit |
T84 |
217-219 |
IN |
denotes |
in |
T85 |
220-228 |
NNS |
denotes |
patients |
T86 |
229-233 |
IN |
denotes |
with |
T87 |
234-242 |
NN |
denotes |
COVID-19 |
T88 |
243-246 |
CC |
denotes |
and |
T89 |
247-251 |
JJ |
denotes |
high |
T90 |
252-255 |
NN |
denotes |
IL6 |
T91 |
258-266 |
NN |
denotes |
Abstract |
T92 |
267-270 |
DT |
denotes |
The |
T93 |
271-276 |
JJ |
denotes |
novel |
T94 |
277-288 |
NN |
denotes |
coronavirus |
T95 |
288-289 |
-COMMA- |
denotes |
, |
T96 |
290-299 |
NN |
denotes |
SARS-CoV2 |
T97 |
299-300 |
-COMMA- |
denotes |
, |
T98 |
301-304 |
MD |
denotes |
can |
R43 |
T51 |
T47 |
arg1Of |
trials,• |
R44 |
T51 |
T48 |
arg1Of |
trials,No |
R45 |
T51 |
T49 |
arg2Of |
trials,controlled |
R46 |
T51 |
T50 |
arg1Of |
trials,clinical |
R47 |
T51 |
T52 |
arg1Of |
trials,exist |
R48 |
T52 |
T53 |
arg1Of |
exist,on |
R49 |
T55 |
T53 |
arg2Of |
use,on |
R50 |
T55 |
T54 |
arg1Of |
use,the |
R51 |
T55 |
T56 |
arg1Of |
use,of |
R52 |
T57 |
T56 |
arg2Of |
corticosteroids,of |
R53 |
T55 |
T58 |
arg1Of |
use,for |
R54 |
T59 |
T58 |
arg2Of |
COVID-19,for |
R55 |
T62 |
T60 |
arg1Of |
correlates,• |
R56 |
T61 |
T62 |
arg1Of |
IL6,correlates |
R57 |
T62 |
T63 |
arg1Of |
correlates,with |
R58 |
T71 |
T63 |
arg2Of |
and,with |
R59 |
T64 |
T65 |
arg1Of |
severity,"," |
R60 |
T66 |
T65 |
arg2Of |
criticality,"," |
R61 |
T65 |
T67 |
arg1Of |
",","," |
R62 |
T69 |
T67 |
arg2Of |
load,"," |
R63 |
T69 |
T68 |
arg1Of |
load,viral |
R64 |
T71 |
T70 |
arg1Of |
and,"," |
R65 |
T67 |
T71 |
arg1Of |
",",and |
R66 |
T72 |
T71 |
arg2Of |
prognosis,and |
R67 |
T72 |
T73 |
arg1Of |
prognosis,of |
R68 |
T74 |
T73 |
arg2Of |
COVID-19,of |
R69 |
T82 |
T75 |
arg1Of |
confer,• |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |
R80 |
T85 |
T86 |
arg1Of |
patients,with |
R81 |
T88 |
T86 |
arg2Of |
and,with |
R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
R83 |
T90 |
T88 |
arg2Of |
IL6,and |
R84 |
T90 |
T89 |
arg1Of |
IL6,high |
R85 |
T94 |
T92 |
arg1Of |
coronavirus,The |
R86 |
T94 |
T93 |
arg1Of |
coronavirus,novel |
R87 |
T94 |
T95 |
arg1Of |
coronavirus,"," |
R88 |
T96 |
T95 |
arg2Of |
SARS-CoV2,"," |
R90 |
T94 |
T98 |
arg1Of |
coronavirus,can |